Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
194 hedge funds and large institutions have $1.99B invested in Amedisys in 2018 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 64 increasing their positions, 69 reducing their positions, and 26 closing their positions.
35% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 26
14% more capital invested
Capital invested by funds: $1.74B → $1.99B (+$251M)
3% more funds holding
Funds holding: 188 → 194 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.2% less ownership
Funds ownership: 97.44% → 97.24% (-0.2%)
7% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 69
25% less call options, than puts
Call options by funds: $3.36M | Put options by funds: $4.5M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$34.9M |
| 2 |
JP Morgan Chase
New York
|
+$32.6M |
| 3 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$20M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$15M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12.7M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$45.5M |
| 2 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
-$31.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.8M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$8.23M |
| 5 |
Two Sigma Investments
New York
|
-$6.92M |
AMED Hedge Fund Activity: Q1 2018 in Review
194 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2018, worth a combined $1.99B — up 14% from $1.74B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new AMED positions and 26 closed out — a net gain of 9 holders — while 64 added to existing stakes and 69 trimmed.
The largest buyer was Ameriprise, adding an estimated $34.9M. The largest seller was Millennium Management, cutting an estimated $45.5M.
- 194 institutional investors held Amedisys (AMED) as of Q1 2018, up from 188 in Q4 2017.
- Funds reported $1.99B of Amedisys stock for Q1 2018, up 14% quarter-over-quarter.
- 35 funds opened new Amedisys positions in Q1 2018 and 26 closed out, a net change of +9 holders.
- The largest Amedisys buyer in Q1 2018 was Ameriprise, an estimated $34.9M added.
- The largest Amedisys seller in Q1 2018 was Millennium Management, an estimated $45.5M sold.
Based on aggregated 13F filings for Q1 2018.